Home / News / Global Molecular Diagnostics Market is expected to grow at the CAGR of 21.3% during 2015-2022 – Brisk Insights

Global Molecular Diagnostics Market is expected to grow at the CAGR of 21.3% during 2015-2022 – Brisk Insights

According to a recently published report, the molecular diagnostics market is expected to grow at the CAGR of 21.3% during 2015-2022. The segmentation of global molecular diagnostics market is based on application, products and services, technology, end users and geography. The report on Global Molecular Diagnostics Market Forecast, 2015-2022 (by application, products and services, technology, end users and geography) provides detailed overview and predictive analysis of the market.

Full report available Global Molecular Diagnostics Market Forecast, 2015-2022 (by application, products and services, technology, end users and geography) report at http://www.briskinsights.com/report/molecular-diagnostics-market

Increasing prevalence rate of types of cancer and infectious diseases are expected to boost the market during the forecasted period of the study. Growing geriatric population is also contributes significantly to the growth of molecular devices market. According to WHO, by 2050 there will be growth of 16% in the geriatric population (65 years and above). China, one of the most populated countries, has numerous opportunities in healthcare which is anticipated to drive the market over the forecasted period. Technological advancements has enabled instruments to provide accurate and fast results. Some of the challenges faced by the molecular diagnostics market are high price of tests and presence of complex regulatory framework. Lack of trained professionals to operate advanced and complex platforms is also acting as a major barrier in the growth of molecular devices market.
Scope of the report
1. Global Molecular diagnostics Market by application, 2012 – 2022 ($ billion)
1.1. Oncology
1.1.1. Breast Cancer
1.1.2. Prostate Cancer
1.1.3. Colorectal Cancer
1.2. Genetic Tests
1.3. Infectious Diseases
1.3.1. Human Immunodeficiency Virus (HIV)
1.3.2. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
1.3.3. Hepatitis B
1.3.4. Tuberculosis (TB)
1.3.5. Hepatitis C
1.3.6. Methicillin-Resistant Staphylococcus Aureus (MRSA)
1.3.7. Human Papillomavirus (HPV)
1.3.8. Others
1.4. Microbiology
1.5. Blood Screening
1.6. Others
2. Global Molecular diagnostics Market by products and services, 2012 – 2022 ($ billion)
2.1. Software & Services
2.2. Reagents
2.3. Instruments
3. Global Molecular diagnostics Market by technology, 2012 – 2022 ($ billion)
3.1. Isothermal Nucleic Acid Amplification Technology (INAAT)
3.2. Hybridization (In-Situ Hybridization & Fish)
3.3. Polymerase Chain Reaction (PCR)
3.4. DNA Sequencing and Next-Generation Sequencing
3.5. Microarrays
3.6. Others
4. Global Molecular diagnostics Market by end users, 2012 – 2022 ($ billion)
4.1. Reference Laboratories
4.2. Hospital/Academic Laboratories
4.3. Other End Users
5. Global molecular diagnostics market, regional outlook, 2012-2022(in $billion)
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Middle East & Africa
5.5. Latin America
6. Company profiles
6.1. Qiagen N.V.
6.2. Hologic, Inc.
6.3. Abbott Laboratories
6.4. Roche Diagnostics
6.5. Grifols
6.6. Becton, Dickinson and Company
6.7. BiomErieux SA
6.8. Siemens Healthcare
6.9. Beckman Coulter Inc.
6.10. Cepheid Inc.
6.11. Alere Inc.
6.12. Bayer Healthcare
6.13. Bio-Rad Laboratories
6.14. Danaher Corporation
6.15. Sysmex Corporation

Global Molecular Diagnostics Market is expected to grow at the CAGR of 21.3% during 2015-2022 – Brisk Insights reviewed on March 28, 2016 by rated 5.0 of 5

Release ID: 1420

About Anuradha Shukla

Check Also

400-400

Recent Release : Global Smart Inhalers Market Size, Share, Trend, Growth, Analysis and Forecast Report 2016 – Acute Market Reports

Global smart inhalers market is estimated to reach $191 million by 2022, growing at a ...